PharVision Advisers’s ESCO Technologies ESE Stock Holding History

PharVision Advisers’s Portfolio ESE Stock Details ESE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,608	Closed	-$314K	–	275
2025 Q4	$314K	Buy	+1,608	New	+$339K	0.16%	243

Other funds holding ESE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PharVision Advisers's ESE Position: Q1 2026 in Review

PharVision Advisers sold out of ESCO Technologies (ESE) in Q1 2026, closing a stake of 1,608 shares — an estimated $314K sold.

PharVision Advisers first reported a position in ESE in Q4 2025 and held it in 1 quarter. The position peaked at $314K in Q4 2025. 432 funds tracked by Wall St. Rank hold ESE as of Q1 2026.

PharVision Advisers reported no remaining ESCO Technologies position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,608 ESCO Technologies shares in Q1 2026, an estimated $314K.
PharVision Advisers first reported a position in ESCO Technologies in Q4 2025 and held it in 1 quarter.
PharVision Advisers's ESCO Technologies position peaked at $314K in Q4 2025.
432 funds tracked by Wall St. Rank held ESCO Technologies as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.